Diversify Advisory Services, LLC Vertex Pharmaceuticals Inc Transaction History
Diversify Advisory Services, LLC
- $2.61 Trillion
- Q2 2025
A detailed history of Diversify Advisory Services, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Diversify Advisory Services, LLC holds 7,291 shares of VRTX stock, worth $3.13 Million. This represents 0.11% of its overall portfolio holdings.
Number of Shares
7,291
Previous 5,773
26.29%
Holding current value
$3.13 Million
Previous $2.91 Billion
2.73%
% of portfolio
0.11%
Previous 0.18%
Shares
6 transactions
Others Institutions Holding VRTX
# of Institutions
1,780Shares Held
235MCall Options Held
1.96MPut Options Held
1.14M-
Capital World Investors Los Angeles, CA28.7MShares$12.3 Billion1.94% of portfolio
-
Vanguard Group Inc Valley Forge, PA24.2MShares$10.4 Billion0.15% of portfolio
-
Black Rock Inc. New York, NY21.3MShares$9.15 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA16.1MShares$6.91 Billion1.5% of portfolio
-
State Street Corp Boston, MA11.8MShares$5.05 Billion0.2% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $110B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...